Scott Young | VP Corporate Communications and IR |
Mike Clayman | CEO and Co-Founder |
David Arkowitz | CFO |
David Maris | Wells Fargo Securities |
Randall Stanicky | RBC Capital Markets |
Elliot Wilbur | Raymond James |
Gary Nachman | BMO Capital Markets |
Patrick Trucchio | Berenberg Capital Markets |
Serge Belanger | Needham |
Francois Brisebois | Laidlaw |
Bruce Jackson | Benchmark Company |
Good afternoon, ladies and gentlemen and welcome to the Flexion Therapeutics First Quarter 2019 Financial Results Conference Call. My name is Kevin and I will be your coordinator today. At this time, all participants are in a listen-only mode.
Before we begin I would like to call your attention to the slides that Company will present today. The slides can be view directly via the webcast on Flexion's website under the Investor's tab or on the 8-K the Company issued this afternoon.